-
1
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women
-
Writing Group for the Women's Health Initiative Investigators
-
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
2
-
-
1842867053
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy
-
The Women's Health Initiative Steering Committee
-
The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-12
-
(2004)
JAMA
, vol.291
, pp. 1701-1712
-
-
-
3
-
-
2342563102
-
-
Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004;217:255-61
-
Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004;217:255-61
-
-
-
-
4
-
-
33646262887
-
Epidemiology of coronary heart disease in women
-
Khaw KT. Epidemiology of coronary heart disease in women. Heart 2006;92:2-4
-
(2006)
Heart
, vol.92
, pp. 2-4
-
-
Khaw, K.T.1
-
5
-
-
0032693599
-
Atherosclerosis is an inflammatory disease
-
Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-20
-
(1999)
Am Heart J
, vol.138
-
-
Ross, R.1
-
6
-
-
0032981919
-
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
-
van Baal WM, Kenemans P, Emeis JJ, et al. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertil Steril 1999;71:663-70
-
(1999)
Fertil Steril
, vol.71
, pp. 663-670
-
-
van Baal, W.M.1
Kenemans, P.2
Emeis, J.J.3
-
7
-
-
0343632564
-
-
Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women - a randomised controlled trial. Thromb Haemost 1999;81:673-5
-
Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women - a randomised controlled trial. Thromb Haemost 1999;81:673-5
-
-
-
-
8
-
-
0032739824
-
Short-term hormone replacement therapy: Reduced plasma levels of soluble adhesion molecules
-
Van Baal WM, Emeis JJ, Kenemans P, et al. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 1999;29:913-21
-
(1999)
Eur J Clin Invest
, vol.29
, pp. 913-921
-
-
Van Baal, W.M.1
Emeis, J.J.2
Kenemans, P.3
-
9
-
-
0036890084
-
The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: A randomized, controlled trial
-
Stork S, von Schacky C, Angerer P. The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 2002;165:301-7
-
(2002)
Atherosclerosis
, vol.165
, pp. 301-307
-
-
Stork, S.1
von Schacky, C.2
Angerer, P.3
-
10
-
-
0034050917
-
Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease
-
Seljeflot I, Arnesen H, Hofstad AE, Os I. Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease. Thromb Haemost 2000;83:944-8
-
(2000)
Thromb Haemost
, vol.83
, pp. 944-948
-
-
Seljeflot, I.1
Arnesen, H.2
Hofstad, A.E.3
Os, I.4
-
11
-
-
0034105495
-
Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease
-
Sbarouni E, Kroupis C, Kyriakides ZS, Koniavitou K, Kremastinos DT. Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease. Eur Heart J 2000;21:975-80
-
(2000)
Eur Heart J
, vol.21
, pp. 975-980
-
-
Sbarouni, E.1
Kroupis, C.2
Kyriakides, Z.S.3
Koniavitou, K.4
Kremastinos, D.T.5
-
12
-
-
0033578463
-
Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
-
Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100:717-22
-
(1999)
Circulation
, vol.100
, pp. 717-722
-
-
Cushman, M.1
Legault, C.2
Barrett-Connor, E.3
-
13
-
-
0034749552
-
Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels
-
Koh KK, Son JW, Ahn JY, et al. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels. Int J Cardiol 2001;81:43-50
-
(2001)
Int J Cardiol
, vol.81
, pp. 43-50
-
-
Koh, K.K.1
Son, J.W.2
Ahn, J.Y.3
-
14
-
-
0037083957
-
The effect of 17beta-estradiol on MCP-1 serum levels in postmenopausal women
-
Stork S, Baumann K, von Schacky C, Angerer P. The effect of 17beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res 2002;53:642-9
-
(2002)
Cardiovasc Res
, vol.53
, pp. 642-649
-
-
Stork, S.1
Baumann, K.2
von Schacky, C.3
Angerer, P.4
-
15
-
-
20744446634
-
Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women
-
Sumino H, Ichikawa S, Ohyama Y, et al. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. J Cardiol 2005;96:148-53
-
(2005)
J Cardiol
, vol.96
, pp. 148-153
-
-
Sumino, H.1
Ichikawa, S.2
Ohyama, Y.3
-
16
-
-
0034660437
-
Plasminogen-activator inhibitor type 1 and coronary artery disease
-
Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342:1792-801
-
(2000)
N Engl J Med
, vol.342
, pp. 1792-1801
-
-
Kohler, H.P.1
Grant, P.J.2
-
17
-
-
0029162314
-
The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones
-
Sobel MI, Winkel CA, Macy LB, Liao P, Bjornsson TD. The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obstet Gynecol 1995;173:801-8
-
(1995)
Am J Obstet Gynecol
, vol.173
, pp. 801-808
-
-
Sobel, M.I.1
Winkel, C.A.2
Macy, L.B.3
Liao, P.4
Bjornsson, T.D.5
-
18
-
-
0036304871
-
Medroxyprogesterone acetate versus norethisterone: Effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures
-
Mueck AO, Seeger H, Wallwiener D. Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. Menopause 2002;9:273-81
-
(2002)
Menopause
, vol.9
, pp. 273-281
-
-
Mueck, A.O.1
Seeger, H.2
Wallwiener, D.3
-
19
-
-
0030784934
-
The effect of transdermal oestradiol and oral progestogens on haemostasis variables
-
Kroon UB, Tengborn L, Rita H, Backstrom AC. The effect of transdermal oestradiol and oral progestogens on haemostasis variables. Br J Obstet Gynaecol 1997;104:32-7
-
(1997)
Br J Obstet Gynaecol
, vol.104
, pp. 32-37
-
-
Kroon, U.B.1
Tengborn, L.2
Rita, H.3
Backstrom, A.C.4
-
20
-
-
0031443428
-
-
Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997;17:3071-8
-
Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997;17:3071-8
-
-
-
-
21
-
-
0035901620
-
Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women
-
Koh KK, Jin DK, Yang SH, et al. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 2001;103:1961-6
-
(2001)
Circulation
, vol.103
, pp. 1961-1966
-
-
Koh, K.K.1
Jin, D.K.2
Yang, S.H.3
-
22
-
-
0034101946
-
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis
-
Teede HJ, McGrath BP, Smolich JJ, et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol 2000;20:1404-9
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1404-1409
-
-
Teede, H.J.1
McGrath, B.P.2
Smolich, J.J.3
-
23
-
-
0034950083
-
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
-
Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 2001;76:13-24
-
(2001)
Fertil Steril
, vol.76
, pp. 13-24
-
-
Lobo, R.A.1
Bush, T.2
Carr, B.R.3
Pickar, J.H.4
-
24
-
-
0032706989
-
The effects of six months treatment with a low-dose of conjugated oestrogens in menopausal women
-
Schlegel W, Petersdorf LI, Junker R, Schulte H, Ebert C, von Eckardstein A. The effects of six months treatment with a low-dose of conjugated oestrogens in menopausal women. Clin Endocrinol 1999;51:643-51
-
(1999)
Clin Endocrinol
, vol.51
, pp. 643-651
-
-
Schlegel, W.1
Petersdorf, L.I.2
Junker, R.3
Schulte, H.4
Ebert, C.5
von Eckardstein, A.6
-
25
-
-
34748878206
-
Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women
-
Karara AH, Hanes V, Alonso A, et al. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women. J Clin Pharmacol 2007;47:1292-302
-
(2007)
J Clin Pharmacol
, vol.47
, pp. 1292-1302
-
-
Karara, A.H.1
Hanes, V.2
Alonso, A.3
|